Stragegic Market Research, Pharmaceuticals, Biotechnology
     
 

Examples of Observant LLC’s Custom Multi-dimensional HIV
Market Research Studies

 
 

Observant LLC brings a wealth of experience in infectious disease to add to its HIV expertise. Recent research engagements in HIV market research include:

Qualitative Segmentation Validation

Qualitative research conducted with HIV/ID specialists and PCPs in the US to yield insight on the rationale driving segment membership and provide guidance in developing a final screening algorithm to identify target physician segments for future marketing initiatives

Fixed-Dose-Combination Market Assessment

Qualitative research with HIV/ID specialists and PCPs in the US, France, Germany, and Spain to assess market opportunity for a potential fixed-dose combination product, assessing its potential fit in the current treatment algorithm (across lines of therapy and patient types) and guide the design of a subsequent quantitative discrete choice study phase of research, and inform the strategic plan and clinical program for the potential combination product

Multi-year Portfolio of Global Research for a Novel Oral Antiretroviral Therapy

Qualitative research ranging from pre-launch messaging work, clinical trial evaluations for new and expanded indications, and post-launch usage assessments were conducted in the US and EU to informed the early stage marketing strategy for this new HIV treatment amid a challenging prescribing environment


Return to Main HIV Page
 
Observant LLC | 1601 Trapelo Road, Suite 255 | Waltham, MA 02451 | 781.642.0644 | info@observant.biz
HOME | RESEARCH EXPERTISE | THERAPEUTIC EXPERTISE | INNOVATIONS | MEDIA AND CASES | LEADERSHIP | CAREERS | CONTACT
Observant Home